Towards Diverse and Effective Question-Answer Pair Generation from Children StorybooksSugyeong Eo, Hyeonseok Moon, Jinsung Kim et al.
Recent advances in QA pair generation (QAG) have raised interest in applying this technique to the educational field. However, the diversity of QA types remains a challenge despite its contributions to comprehensive learning and assessment of children. In this paper, we propose a QAG framework that enhances QA type diversity by producing different interrogative sentences and implicit/explicit answers. Our framework comprises a QFS-based answer generator, an iterative QA generator, and a relevancy-aware ranker. The two generators aim to expand the number of candidates while covering various types. The ranker trained on the in-context negative samples clarifies the top-N outputs based on the ranking score. Extensive evaluations and detailed analyses demonstrate that our approach outperforms previous state-of-the-art results by significant margins, achieving improved diversity and quality. Our task-oriented processes are consistent with real-world demand, which highlights our system's high applicability.
14.0LGAug 15, 2019
Self-Attention Based Molecule Representation for Predicting Drug-Target InteractionBonggun Shin, Sungsoo Park, Keunsoo Kang et al.
Predicting drug-target interactions (DTI) is an essential part of the drug discovery process, which is an expensive process in terms of time and cost. Therefore, reducing DTI cost could lead to reduced healthcare costs for a patient. In addition, a precisely learned molecule representation in a DTI model could contribute to developing personalized medicine, which will help many patient cohorts. In this paper, we propose a new molecule representation based on the self-attention mechanism, and a new DTI model using our molecule representation. The experiments show that our DTI model outperforms the state of the art by up to 4.9% points in terms of area under the precision-recall curve. Moreover, a study using the DrugBank database proves that our model effectively lists all known drugs targeting a specific cancer biomarker in the top-30 candidate list.